# DESCRIPTION

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE DISCLOSURE

- describe cardiovascular disease
- discuss limitations of current treatments

## SUMMARY OF THE DISCLOSURE

- introduce method of inducing cardiomyocyte maturation
- describe 3D cardiac ECM scaffold
- outline various embodiments of method
- discuss advantages of mature cardiomyocytes
- summarize compositions and methods

## DETAILED DESCRIPTION

- incorporate references
- define technical terms
- introduce immature cell definition
- introduce cardiac microenvironment definition
- introduce seeding definition
- describe method of making mature cardiomyocytes
- describe inducing cardiomyocyte maturation
- describe harvesting mature cardiomyocytes
- describe 3D cardiac ECM scaffold preparation
- describe mature cardiomyocyte application in drug screening
- describe mature cardiomyocyte application in tissue engineering therapy
- describe method of treating disease in a mammal
- describe composition comprising 3D ECM scaffold and cardiomyocytes
- describe method of inducing cardiomyocyte maturation with endothelial cells
- describe method of using mature cardiomyocytes as a drug screening platform
- describe method of treating cardiovascular disease in a mammal
- describe method for prognosing cardiovascular disease
- describe pharmaceutical composition and administration

### EXAMPLES

- introduce iPSC maintenance and cardiac differentiation
- describe cardiac tissue decellularization and extracellular matrix generation
- introduce multiphoton imaging and fiber analysis
- describe statistical analysis
- introduce iPSC-derived cardiomyocyte maturation
- describe 2D and 3D culture methods
- introduce quantitative RT-PCR
- describe calcium imaging and analysis
- introduce pharmacological treatment of cardiomyocytes
- describe nanoLC-MS/MS analysis
- introduce mechanical analysis of 3D cardiac extracellular matrix hydrogels
- describe flow cytometry
- introduce immunocytochemistry
- describe hydrogel encapsulation of human iPS-cardiomyocyte spheroids
- introduce characterization of extracellular matrix from decellularized adult and fetal bovine cardiac tissue
- describe protein composition analysis by nano-LC MS/MS
- introduce 3D adult cardiac extracellular matrix promotes expression of cardiomyocytes maturation genes
- describe cardiac extracellular matrix geometry affects iPSC-derived cardiomyocytes calcium signaling
- introduce 3D adult cardiac extracellular matrix increases iPSC-derived cardiomyocyte response to drugs
- describe cardiac differentiation
- introduce endothelial cell isolation
- describe EC co-culture and condition medium
- describe example 21 gPCR
- describe effect of EC on CM maturation
- describe inhibition of ET and notch signaling
- describe cardiomyocytes and cardiac extracellular matrix
- describe properties of native cardiac extracellular matrix
- describe 3D conformation advantages
- describe biomechanical cues
- describe fetal and adult cardiac extracellular matrix
- describe induction of maturation genes
- describe calcium handling genes
- describe calcium flux reporter GCaMP6
- describe response to drugs
- describe 3D adult cardiac extracellular matrix
- describe endothelial cells
- describe endothelin and notch signaling
- motivate cardiomyocyte maturation
- describe cardiac micro-environment
- illustrate cardiac ECM promotes CM maturation
- describe endothelial cells promote CM maturation
- detail cardiac ECM preparation
- outline CM differentiation
- describe cardiac tissues
- detail vasculature and other cell types
- discuss various methods and techniques
- provide disclaimer and scope of invention
- conclude and provide references

